BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34821660)

  • 1. Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis.
    Yin S; Liu Y; Dai S; Zhang B; Qu Y; Zhang Y; Choe WS; Bi J
    Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting.
    Jiang B; Jia X; Ji T; Zhou M; He J; Wang K; Tian J; Yan X; Fan K
    Sci China Life Sci; 2022 Feb; 65(2):328-340. PubMed ID: 34482518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
    Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
    Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High hydrostatic pressure encapsulation of doxorubicin in ferritin nanocages with enhanced efficiency.
    Wang Q; Zhang C; Liu L; Li Z; Guo F; Li X; Luo J; Zhao D; Liu Y; Su Z
    J Biotechnol; 2017 Jul; 254():34-42. PubMed ID: 28591619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat sensitive E-helix cut ferritin nanocages for facile and high-efficiency loading of doxorubicin.
    Xia H; Xu H; Wang J; Wang C; Chen R; Tao T; Xu S; Zhang J; Ma K; Wang J
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126973. PubMed ID: 37729988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
    Liang M; Fan K; Zhou M; Duan D; Zheng J; Yang D; Feng J; Yan X
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14900-5. PubMed ID: 25267615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cargo loading within ferritin nanocages in preparation for tumor-targeted delivery.
    Zhang J; Cheng D; He J; Hong J; Yuan C; Liang M
    Nat Protoc; 2021 Oct; 16(10):4878-4896. PubMed ID: 34497386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization.
    Yin S; Wang Y; Zhang B; Qu Y; Liu Y; Dai S; Zhang Y; Wang Y; Bi J
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending Half Life of H-Ferritin Nanoparticle by Fusing Albumin Binding Domain for Doxorubicin Encapsulation.
    Wang C; Zhang C; Li Z; Yin S; Wang Q; Guo F; Zhang Y; Yu R; Liu Y; Su Z
    Biomacromolecules; 2018 Mar; 19(3):773-781. PubMed ID: 29328653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of purification process for dual-function recombinant human heavy-chain ferritin by the investigation of genetic modification impact on conformation.
    Yin S; Zhang B; Lin J; Liu Y; Su Z; Bi J
    Eng Life Sci; 2021 Oct; 21(10):630-642. PubMed ID: 34690634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin α
    Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
    J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferritin Nanocaged Doxorubicin Potentiates Chemo-Immunotherapy against Hepatocellular Carcinoma via Immunogenic Cell Death.
    Chen Y; Zeng L; Zhu H; Wu Q; Liu R; Liang Q; Chen B; Dai H; Tang K; Liao C; Huang Y; Yan X; Fan K; Du JZ; Lin R; Wang J
    Small Methods; 2023 May; 7(5):e2201086. PubMed ID: 36446639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells.
    Bellini M; Mazzucchelli S; Galbiati E; Sommaruga S; Fiandra L; Truffi M; Rizzuto MA; Colombo M; Tortora P; Corsi F; Prosperi D
    J Control Release; 2014 Dec; 196():184-96. PubMed ID: 25312541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferritin-Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy.
    Liu R; Liang Q; Luo JQ; Li YX; Zhang X; Fan K; Du JZ
    Adv Sci (Weinh); 2024 Jan; 11(3):e2305217. PubMed ID: 38029345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered protein cages with enhanced extracellular drug release for elevated antitumor efficacy.
    Yan W; Li H; Ning J; Huang S; Jiang L; Xu P; Huang M; Yuan C
    Int J Biol Macromol; 2024 May; 267(Pt 1):131492. PubMed ID: 38604418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.
    Wang Z; Zhao Y; Zhang S; Chen X; Sun G; Zhang B; Jiang B; Yang Y; Yan X; Fan K
    Theranostics; 2022; 12(4):1800-1815. PubMed ID: 35198074
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of TFR-1 Expression in Feline Mammary Cancer and In Vitro Antitumor Efficacy Study of Doxorubicin-Loaded H-Ferritin Nanocages.
    Rensi N; Sammarco A; Moccia V; Calore A; Torrigiani F; Prosperi D; Rizzuto MA; Bellini M; De Maria R; Bonsembiante F; Ferro S; Zanetti R; Zappulli V; Cavicchioli L
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax.
    Sitia L; Bonizzi A; Mazzucchelli S; Negri S; Sottani C; Grignani E; Rizzuto MA; Prosperi D; Sorrentino L; Morasso C; Allevi R; Sevieri M; Silva F; Truffi M; Corsi F
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild Acid-Responsive "Nanoenzyme Capsule" Remodeling of the Tumor Microenvironment to Increase Tumor Penetration.
    Yao H; Guo X; Zhou H; Ren J; Li Y; Duan S; Gong X; Du B
    ACS Appl Mater Interfaces; 2020 May; 12(18):20214-20227. PubMed ID: 32248684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.